How to Read Ad Phrases Like “Physician-Supervised” and “Proprietary Formula” — What to Know Before Choosing Hair Regenerative Medicine, Explained by Dr. Moriwaki2026.07.18

“This clinic is physician-supervised, so you can trust it.” “We use a stem cell conditioned media made with our own proprietary formula.” — When you look into hair regenerative medicine, you will run into these phrases everywhere. Yet neither “supervised” nor “proprietary” has a defined meaning under Japan’s medical advertising guidelines. The vaguer the word, the more the reader has to weigh it themselves. In this article, Dr. Moriwaki lays out how to read the gradient behind the words commonly used in hair regenerative medicine advertising, so patients and clinicians can judge them by the same yardstick.

Key Points of This Article

・Neither “physician-supervised” nor “proprietary formula” is a legal certification; they are the most easily misread expressions in hair regenerative medicine advertising.

・What “supervised” really means varies wildly — a full-time attending, a nominal advisor, or a name loaned to a website.

・To judge a “proprietary formula,” look at whether the clinic discloses the source cells, culture conditions, sterility testing, and lot management.

・Ahead of any catchy ad phrase, prioritize confirming the notification number, the licensed manufacturing facility, and the presence of a CoA (lot certificate).

・Hair regenerative medicine is a multi-year commitment; choosing on “price” and “impression from words” carries real risk.

“Physician-Supervised” — Who Is Involved, and How Deeply?

The word “supervised” (kanshu) has no legal definition in medical advertising. Japan’s medical advertising guidelines regulate misleading statements, testimonials, and before-and-after photos, but the word itself is not banned. As a result, even a doctor who simply lends their name can be listed as the “supervising physician” in ads.

For hair regenerative medicine specifically, ask three things. First, is the doctor a full-time attending at the clinic, or a non-resident advisor? Second, who is the actual physician performing the procedure that day, and what is their experience with hair regenerative medicine? Third, how does the supervising physician participate in decisions about treatment policy, agents used, and dosing protocol? Clinics that can answer all three are running “supervision” as a system, not just a signboard.

Even a claim like “Our supervisor is a professor at a famous university hospital” does not mean that professor personally handles hair regenerative medicine day to day. Separating clinical specialty from advertising authority is a core piece of patient-side literacy.

How to Judge What a “Proprietary Formula” Really Is in Hair Regenerative Medicine

“Our original,” “proprietary blend,” “custom conditioned media” — these lines fill the ad copy. But in most cases, the clinic is not culturing cells in-house; it is purchasing lot products from an external, licensed processing facility for specified cell products. In that setup, “proprietary” usually refers to the clinic’s own way of using the product — concentration, injection layer, frequency — rather than the drug itself.

To judge the actual substance, check the disclosure of: the source cell (umbilical cord, adipose, dental pulp); whether the culture is serum-free or uses fetal bovine serum (FBS); whether sterility, mycoplasma, and endotoxin tests are performed; and whether a per-lot CoA (Certificate of Analysis) is disclosed. These are the objective indicators behind the word “proprietary.”

Conversely, a clinic that answers such questions only with “that’s a trade secret” may be underweighting its duty to explain to patients. Because hair regenerative medicine runs on a multi-year horizon, the transparency of the agent directly affects the risk-benefit of every single session.

hair regenerative medicine advertising literacy clinic selection

Before Ad Wording — Check the Notification and Legal Framework

When a treatment uses stem cell conditioned media or exosome-related agents, it may require a notification under the Japanese Act on the Safety of Regenerative Medicine. Depending on Class I, II, or III risk classification, the plan is reviewed by a certified regenerative medicine committee and then filed with the regional health bureau. Once accepted, a plan number is assigned and can be searched on the Ministry of Health, Labour and Welfare’s public site.

That plan number, the plan name, and the implementing institution are far more objective safety signals than the impact of phrases like “physician-supervised” or “proprietary formula.” Conversely, if the treatment requires a filing but the clinic does not disclose the number, it is quite reasonable to remove that clinic from your shortlist right there.

For oral and topical AGA treatment, the Japanese Dermatological Association publishes clinical guidelines. Grasping — even at a high level — the recommendation strengths for finasteride, dutasteride, and minoxidil, and where regenerative approaches such as stem cell conditioned media sit relative to them, makes the gap between advertising and actual evidence easier to spot. For details, see the Japanese Dermatological Association.

How to Read Numbers Like “No. 1 Case Volume” or “98% Satisfaction”

Numbers feel concrete, which is why they earn trust so easily — but without the population, the period, and the methodology, they cannot become a judgment tool. “No. 1 case volume” may mean “in a self-defined category and self-counted.” “98% satisfaction” may come from a survey with a low response rate, which changes its practical meaning entirely.

Outcomes in hair regenerative medicine swing widely with baseline severity, age, lifestyle, concurrent treatment, and dosing interval. So “X% improvement” is a headline that needs a follow-up question: where does my situation sit inside that population? Signing based on numbers alone means transferring someone else’s result — obtained under different conditions — onto yourself.

To build a habit of second opinions and cross-clinic comparison, start by touching multiple information sources. In-clinic treatment results and past column articles are available on our hair regenerative medicine column list.

Why Patients With Ad Literacy End Up Better Off Long-Term in Hair Regenerative Medicine

Hair regenerative medicine takes months to reach a first efficacy read-out and years when maintenance is included. Choosing a clinic upfront on “price,” “flashy phrases,” or “today-only discount” and later discovering it was actually more expensive once dosing intervals, testing, and follow-up are counted is not a rare story.

Patients who can weigh words calmly enter the first visit with clearer checkpoints: notification number, the actual role of the supervising physician, lot management of the agent, the rationale for the dosing protocol, and the criteria for stopping or changing. Preparing these in advance as a question list already lifts the quality of your decision considerably.

Dr. Moriwaki’s clinical experience is that patients who can think for themselves — rather than being pulled along by ad language — calibrate their expectations better mid-treatment and end up more satisfied. Hair regenerative medicine is a treatment that should be chosen by “disclosure,” not by “wording.”

Frequently Asked Questions

Q. If it says “physician-supervised,” can I just trust it?

Not on its own — “supervised” has no legal definition. Confirm who is involved and how, who actually performs the procedure that day, and who decides the dosing protocol. Whether “supervision” is a signboard or an operating system is the real criterion.

Q. Does a “proprietary formula” stem cell conditioned media mean the clinic makes it themselves?

Usually no. Most conditioned media are lot products manufactured at external, licensed processing facilities and purchased by the clinic. “Proprietary” typically refers to how the clinic uses the product — dosing protocol and technique — rather than the drug itself. Asking for the CoA (Certificate of Analysis) reveals what is actually inside.

Q. Where can I check the notification (plan) number?

The Ministry of Health, Labour and Welfare publishes accepted regenerative medicine provision plans by institution and plan name. The most reliable approach is to ask for the plan number at your consultation and cross-check it at home. Clinics that cannot disclose a number should be approached with caution.

Q. Can I trust “No. 1 case volume” or “98% satisfaction”?

Without the underlying counting method, population, and period, they are not comparison material. It is far more useful to ask, in cases whose age, severity, and goal resemble yours, how much change was actually seen.

Q. What should I confirm before signing a contract?

The notification number, the actual role of the supervising physician, the treating physician’s experience, lot management of the agent, the rationale for the dosing protocol, the timing of efficacy assessment, and the conditions for stopping, changing, or refund. Bringing a question list built around these keeps you from being swayed by ad wording.

──────────────

【Supervising Physician】Dr. Shin Moriwaki

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG certificate (US medical license qualification)

──────────────

📍AVAN TOKYO 銀座毛髪再生医療

AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt available